secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vir Biotechnology, Inc. (VIR)
CIK:        0001706431
Form:       8-K
Filed at:   2022-07-14T23:59:59+00:00
Accession:  0001193125-22-193370
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Vir Biotechnology CSO Herbert (Skip) Virgin steps down effective August 31, 2022
--------------------------------------------------------------------------------

- Herbert (Skip) Virgin, M.D., Ph.D., notified the company on July 11, 2022.
- He will resign as EVP, Research and Chief Scientific Officer effective August 31, 2022.
- No replacement or interim appointment has been announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1706431/000119312522193370/0001193125-22-193370-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1706431/000119312522193370/d379155d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-193370

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer